文献速递其他结缔组织病

肢带型肌营养不良R12(LGMD 2L,anoctaminopathy)易误诊为特发性炎性肌病:防误诊要点

Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本文回顾性分析了4例初诊被误诊为特发性炎性肌病(IIM)的肢带型肌营养不良R12(LGMD 2L,anoctaminopathy)患者,总结临床、实验室、肌肉影像及组织学特点。患者接受免疫抑制治疗(其中1例超过15年)均未见明确疗效,自身抗体阴性且无结缔组织病特征,大腿MRI常见显著脂肪浸润与选择性肌肉受累。提示成人起病遗传性肌病可模仿IIM,准确诊断可避免有害免疫抑制治疗并利于遗传咨询。

要点

  • 免疫抑制治疗无明确疗效、自身抗体阴性时应警惕遗传性肌病。
  • 大腿MRI显著脂肪浸润与选择性肌肉受累是提示LGMD R12的影像线索。
  • 确诊LGMD R12可避免不必要免疫抑制、支持遗传咨询与研究入组。

核心结论

  • 成人起病的遗传性肌病尤其是LGMD R12可模仿特发性炎性肌病,准确诊断至关重要。

研究设计与样本

  • 对4例曾被误诊为IIM的LGMD 2L患者进行病历、实验室结果、肌肉影像和组织学发现的回顾性复习。

主要发现

  • 3例男性、1例女性,就诊时平均年龄51岁;免疫抑制治疗均无明确治疗反应,其中1例治疗超过15年。
  • 所有患者抗核抗体及可检测的肌炎相关/特异性自身抗体均阴性,且无相关结缔组织病特征。
  • 大腿MRI共同表现为显著脂肪浸润和选择性肌肉受累。

关键数值与推荐

  • 4例LGMD 2L患者中3例男性、1例女性,就诊时平均年龄51岁;1例免疫抑制治疗超过15年且无明确疗效。

临床怎么用

  • 对拟诊IIM但自身抗体阴性、无结缔组织病特征且免疫抑制治疗无反应者,应考虑遗传性肌病并借助大腿MRI模式识别与遗传评估。
  • 确诊LGMD R12后应避免不必要免疫抑制治疗,并提供遗传咨询及研究入组机会。

局限性

  • 为4例患者的回顾性病例复习,样本量小,未提供诊断标准、随访时长及统计比较等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Diagnosing the idiopathic inflammatory myopathies (IIMs) can be challenging as several conditions, including genetic myopathies such as limb girdle muscular dystrophy type R12 (LGMD 2 l, anoctaminopathy) mimic the presentation. Here we describe learning points identified from review of four patients with LGMD 2 l who were initially incorrectly diagnosed with IIM. Our aim is to provide clinicians working in adult rheumatology services with a toolkit to help identify non-inflammatory presentations of myopathy. METHODS: We performed retrospective review of medical notes, laboratory results, muscle imaging and histological findings of four patients with LGMD 2 l who were previously misdiagnosed with IIM. We focussed on clinical presentation and progression, therapeutic agents used and events leading to revision of the diagnosis. RESULTS: Three male patients and one female patient with a mean age of 51 years at presentation were reviewed. In each case, treatment with immunosuppressants, in one case for >15 years, was observed without a clear therapeutic response. All patients were negative for anti-nuclear antibodies and available myositis-associated/specific autoantibodies and associated connective tissue disease features were absent. Prominent fatty infiltration and selective muscle involvement on thigh MRI was found in common. CONCLUSIONS: Adult-onset genetic myopathies, particularly LGMD R12, can mimic IIM. Accurate diagnosis is crucial to avoid the use of potentially harmful immunosuppressive therapies, to allow appropriate genetic counselling and to facilitate involvement in research studies.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Marago I, Roberts M, Roncaroli F, et al. Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis. Rheumatology (Oxford). 2022. PMID: 34264321. doi:10.1093/rheumatology/keab553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。